181 related articles for article (PubMed ID: 36423586)
1. Luteolin Attenuates Diabetic Myocardial Hypertrophy by Inhibiting Proteasome Activity.
Li XB; Rekep M; Tian JH; Wu Q; Chen M; Yang S; Zhang LX; Zhang GP; Qin Y; Yu XY; Xue Q; Liu YH
Pharmacology; 2023; 108(1):47-60. PubMed ID: 36423586
[TBL] [Abstract][Full Text] [Related]
2. Quercetin Prevents In Vivo and In Vitro Myocardial Hypertrophy Through the Proteasome-GSK-3 Pathway.
Chen K; Rekep M; Wei W; Wu Q; Xue Q; Li S; Tian J; Yi Q; Zhang G; Zhang G; Xiao Q; Luo J; Liu Y
Cardiovasc Drugs Ther; 2018 Feb; 32(1):5-21. PubMed ID: 29435775
[TBL] [Abstract][Full Text] [Related]
3. Zonisamide attenuates pressure overload-induced myocardial hypertrophy in mice through proteasome inhibition.
Wu Q; Liu WJ; Ma XY; Chang JS; Zhao XY; Liu YH; Yu XY
Acta Pharmacol Sin; 2024 Apr; 45(4):738-750. PubMed ID: 38097716
[TBL] [Abstract][Full Text] [Related]
4. Sitagliptin attenuates myocardial apoptosis via activating LKB-1/AMPK/Akt pathway and suppressing the activity of GSK-3β and p38α/MAPK in a rat model of diabetic cardiomyopathy.
Al-Damry NT; Attia HA; Al-Rasheed NM; Al-Rasheed NM; Mohamad RA; Al-Amin MA; Dizmiri N; Atteya M
Biomed Pharmacother; 2018 Nov; 107():347-358. PubMed ID: 30099338
[TBL] [Abstract][Full Text] [Related]
5. Luteolin protects against diabetic cardiomyopathy by inhibiting NF-κB-mediated inflammation and activating the Nrf2-mediated antioxidant responses.
Li L; Luo W; Qian Y; Zhu W; Qian J; Li J; Jin Y; Xu X; Liang G
Phytomedicine; 2019 Jun; 59():152774. PubMed ID: 31009852
[TBL] [Abstract][Full Text] [Related]
6. Berberine treatment prevents cardiac dysfunction and remodeling through activation of 5'-adenosine monophosphate-activated protein kinase in type 2 diabetic rats and in palmitate-induced hypertrophic H9c2 cells.
Chang W; Zhang M; Meng Z; Yu Y; Yao F; Hatch GM; Chen L
Eur J Pharmacol; 2015 Dec; 769():55-63. PubMed ID: 26522928
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis of cardiomyocytes in diabetic cardiomyopathy involves overexpression of glycogen synthase kinase-3β.
Wu W; Liu X; Han L
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30237226
[TBL] [Abstract][Full Text] [Related]
8. Guan Xin Dan Shen formulation protects
Zhang B; Zhang CY; Zhang XL; Sun GB; Sun XB
Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 34036388
[TBL] [Abstract][Full Text] [Related]
9. Urocortin attenuates myocardial fibrosis in diabetic rats via the Akt/GSK-3β signaling pathway.
Liu X; Liu C; Li J; Zhang X; Song F; Xu J
Endocr Res; 2016 May; 41(2):148-57. PubMed ID: 26934363
[TBL] [Abstract][Full Text] [Related]
10. FNDC5/Irisin attenuates diabetic cardiomyopathy in a type 2 diabetes mouse model by activation of integrin αV/β5-AKT signaling and reduction of oxidative/nitrosative stress.
Lin C; Guo Y; Xia Y; Li C; Xu X; Qi T; Zhang F; Fan M; Hu G; Zhao H; Zhao H; Liu R; Gao E; Yan W; Tao L
J Mol Cell Cardiol; 2021 Nov; 160():27-41. PubMed ID: 34224725
[TBL] [Abstract][Full Text] [Related]
11. Curcumin alleviates diabetic cardiomyopathy in experimental diabetic rats.
Yu W; Wu J; Cai F; Xiang J; Zha W; Fan D; Guo S; Ming Z; Liu C
PLoS One; 2012; 7(12):e52013. PubMed ID: 23251674
[TBL] [Abstract][Full Text] [Related]
12. Methazolamide Attenuates the Development of Diabetic Cardiomyopathy by Promoting β-Catenin Degradation in Type 1 Diabetic Mice.
Chen X; Li Y; Yuan X; Yuan W; Li C; Zeng Y; Lian Y; Qiu X; Qin Y; Zhang G; Liu X; Luo C; Luo JD; Hou N
Diabetes; 2022 Apr; 71(4):795-811. PubMed ID: 35043173
[TBL] [Abstract][Full Text] [Related]
13. Acupuncture Reduces Hypertrophy and Cardiac Fibrosis, and Improves Heart Function in Mice with Diabetic Cardiomyopathy.
Ye Y; Birnbaum Y; Widen SG; Zhang Z; Zhu S; Bajaj M; Chen H
Cardiovasc Drugs Ther; 2020 Dec; 34(6):835-848. PubMed ID: 32767170
[TBL] [Abstract][Full Text] [Related]
14. Luteolin ameliorates cardiac failure in type I diabetic cardiomyopathy.
Wang G; Li W; Lu X; Bao P; Zhao X
J Diabetes Complications; 2012; 26(4):259-65. PubMed ID: 22626874
[TBL] [Abstract][Full Text] [Related]
15. Obestatin induced recovery of myocardial dysfunction in type 1 diabetic rats: underlying mechanisms.
Aragno M; Mastrocola R; Ghé C; Arnoletti E; Bassino E; Alloatti G; Muccioli G
Cardiovasc Diabetol; 2012 Oct; 11():129. PubMed ID: 23066908
[TBL] [Abstract][Full Text] [Related]
16. Pyrroloquinoline quinone ameliorates diabetic cardiomyopathy by inhibiting the pyroptosis signaling pathway in C57BL/6 mice and AC16 cells.
Qu XF; Zhai BZ; Hu WL; Lou MH; Chen YH; Liu YF; Chen JG; Mei S; You ZQ; Liu Z; Zhang LJ; Zhang YH; Wang Y
Eur J Nutr; 2022 Jun; 61(4):1823-1836. PubMed ID: 34997266
[TBL] [Abstract][Full Text] [Related]
17. Argatroban Attenuates Diabetic Cardiomyopathy in Rats by Reducing Fibrosis, Inflammation, Apoptosis, and Protease-Activated Receptor Expression.
Bulani Y; Sharma SS
Cardiovasc Drugs Ther; 2017 Jun; 31(3):255-267. PubMed ID: 28695302
[TBL] [Abstract][Full Text] [Related]
18. Dapagliflozin Ameliorates STZ-Induced Cardiac Hypertrophy in Type 2 Diabetic Rats by Inhibiting the Calpain-1 Expression and Nuclear Transfer of NF-
Liu L; Luo H; Liang Y; Tang J; Shu Y
Comput Math Methods Med; 2022; 2022():3293054. PubMed ID: 35096128
[TBL] [Abstract][Full Text] [Related]
19. The protection of luteolin against diabetic cardiomyopathy in rats is related to reversing JNK-suppressed autophagy.
Xiao C; Chen MY; Han YP; Liu LJ; Yan JL; Qian LB
Food Funct; 2023 Mar; 14(6):2740-2749. PubMed ID: 36852907
[TBL] [Abstract][Full Text] [Related]
20. Oral treatment with a zinc complex of acetylsalicylic acid prevents diabetic cardiomyopathy in a rat model of type-2 diabetes: activation of the Akt pathway.
Korkmaz-Icöz S; Al Said S; Radovits T; Li S; Brune M; Hegedűs P; Atmanli A; Ruppert M; Brlecic P; Lehmann LH; Lahrmann B; Grabe N; Yoshikawa Y; Yasui H; Most P; Karck M; Szabó G
Cardiovasc Diabetol; 2016 May; 15():75. PubMed ID: 27153943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
